LINEZOLID IN COMPLICATED DRUG-RESISTANT TUBERCULOSIS

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 37

Abstract

BACKGROUND The treatment for Drug-Resistant Tuberculosis (DR-TB) is not adequate and outcomes are poorer than for drug-susceptible TB, particularly for patients treated for second-line drugs, treatment failures or extensively drug-resistant (XDR-TB) patients (Complicated DR-TB). Linezolid is not recommended for routine DR-TB treatment due to lack of efficacy data but is indicated in case where 2nd line regimens are difficult to design. MATERIALS AND METHODS We searched PubMed,Embase and Abstracts from World Conferences of The union for Studies published through February 2011. In these Linezolid was given systematically to DR-TB Patient and outcomes were reported. RESULTS A total of 11 studies were included representing 148 patients. The pooled proportion for treatment success was 67.99%. There was no significant differences in success comparing daily Linezolid dose (600 vs 600 mg) and mean Linezolid duration ( 7 vs 7 months). The pooled estimate for the frequency of any adverse events was 61.48% (95%CI 40.15-82.80) with 36.23% (95%CI 20.67-51.79) discontinuing Linezolid due to adverse events. CONCLUSION Treatment success with Linezolid was equal to or better than that commonly achieved for uncomplicated DR-TB and better than previous reports for previously treated patient and those with XDR-TB while data are limited. Linezolid appears to be a useful drug albeit associated with significant adverse events and could be considered for the treatment of complicated DR-TB.

Authors and Affiliations

Mohammed Umar Farooque

Keywords

Related Articles

APPLICATION OF MONTGOMERY TUBE IN A CASE OF SUBGLOTTIC STENOSIS

PRESENTATION OF CASE A 24 year old male having meningitis was on ventilatory support for 15 days. He was discharged from hospital after 25 days of hospitalization. After 10 days he came to emergency ward with complaints...

ANESTHETIC MANAGEMENT OF A PATIENT WITH IMPLANTED PERMANENT PACEMAKER FOR EXCISION OF PHEOCHROMOCYTOMA

Pheochromocytoma is a potentially lethal catecholamine secreting tumor of chromaffin tissues of the adrenal medulla and sympathetic chain. [1] Incidence across the globe is around 1 to 2 per million population. [2] Repor...

A STUDY OF PREVALENCE OF DEPRESSION AND ANXIETY IN PATIENTS WITH PEMPHIGUS VULGARIS- A CROSS SECTIONAL STUDY

BACKGROUND Psychiatric disorders in pemphigus vulgaris may occur due to long term course, impact of body image, unlikelihood of complete recovery and frequent recurrences. These are the major predisposing factors towards...

COMPARATIVE STUDY BETWEEN CT SCAN AND AUTOPSY FINDINGS IN TRAUMATIC BRAIN INJURY WITH SPECIAL REFERENCE TO DAI

BACKGROUND Traumatic brain injury (TBI), a significant public health problem, is a leading cause of disability and mortality in all regions of the globe despite advancement in prevention and treatments. Diffuse Axonal In...

MRI STUDY OF ANKLE: TALAR LENGTH AND MALLEOLAR INDEX

Ankle instability has been correlated with many factors such as peroneal muscle weakness, varus hind foot. However knowledge of the measurement of malleolar index and maximum talar length and their correlation with each...

Download PDF file
  • EP ID EP219084
  • DOI 10.18410/jebmh/2017/437
  • Views 111
  • Downloads 0

How To Cite

Mohammed Umar Farooque (2017). LINEZOLID IN COMPLICATED DRUG-RESISTANT TUBERCULOSIS. Journal of Evidence Based Medicine and Healthcare, 4(37), 2231-2239. https://www.europub.co.uk/articles/-A-219084